ArticleJournal of gastroenterology2018

Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.

Norio Akuta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.